Neglected Tropical Diseases Diagnosis Market Size, Trends, Analysis, and Outlook By Disease (Dengue, Chikungunya, Rabies, Leprosy, Buruli ulcer, Yaws, Lymphatic Filariasis, Taeniasis/Cysticercosis, Foodborne trematode infections, Echinococcosis, Chagas di

Neglected Tropical Diseases Diagnosis Market Size, Trends, Analysis, and Outlook By Disease (Dengue, Chikungunya, Rabies, Leprosy, Buruli ulcer, Yaws, Lymphatic Filariasis, Taeniasis/Cysticercosis, Foodborne trematode infections, Echinococcosis, Chagas disease, Dracunculiasis, Human African trypanosomiasis (sleeping sickness), Soil-transmitted helminthiases, Onchocerciasis, Schistosomiasis, Scabies, Snakebite Envenoming, Leishmaniases), By Diagnostic Method (Conventional Method, Molecular/Modern Method), By Service (Centralized Service, POC Service), By End-user (Clinical Labs, Hospitals /Clinics, Home Healthcare), by Region, Country, Segment, and Companies, 2024-2030

The global Neglected Tropical Diseases Diagnosis market size is poised to register 4.66% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Neglected Tropical Diseases Diagnosis market across By Disease (Dengue, Chikungunya, Rabies, Leprosy, Buruli ulcer, Yaws, Lymphatic Filariasis, Taeniasis/Cysticercosis, Foodborne trematode infections, Echinococcosis, Chagas disease, Dracunculiasis, Human African trypanosomiasis (sleeping sickness), Soil-transmitted helminthiases, Onchocerciasis, Schistosomiasis, Scabies, Snakebite Envenoming, Leishmaniases), By Diagnostic Method (Conventional Method, Molecular/Modern Method), By Service (Centralized Service, POC Service), By End-user (Clinical Labs, Hospitals /Clinics, Home Healthcare).

The Neglected Tropical Diseases Diagnosis Market is witnessing growth driven by the global efforts to control and eliminate neglected tropical diseases (NTDs), such as malaria, dengue fever, Chagas disease, and leishmaniasis, through improved disease surveillance, early detection, and access to diagnostic testing. Neglected tropical diseases disproportionately affect low-income and resource-limited regions, posing significant public health challenges and socioeconomic burdens. Key trends shaping its future include the development of rapid diagnostic tests (RDTs) and point-of-care (POC) assays for decentralized and community-based screening and surveillance of NTDs in endemic areas with limited healthcare infrastructure, the integration of multiplex and molecular diagnostic technologies for simultaneous detection of multiple NTD pathogens and co-infections, and the customization of diagnostic algorithms and surveillance strategies to address specific disease epidemiologies, transmission dynamics, and control priorities. Moreover, factors such as the investments in NTD research and development, the collaborations between governments, non-profit organizations, and pharmaceutical companies, and the initiatives for universal health coverage and global health security are expected to drive market growth in 2024 and beyond.

Neglected Tropical Diseases Diagnosis Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Neglected Tropical Diseases Diagnosis market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Neglected Tropical Diseases Diagnosis survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Neglected Tropical Diseases Diagnosis industry.

Key market trends defining the global Neglected Tropical Diseases Diagnosis demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Neglected Tropical Diseases Diagnosis Market Segmentation- Industry Share, Market Size, and Outlook to 2030

The Neglected Tropical Diseases Diagnosis industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Neglected Tropical Diseases Diagnosis companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Neglected Tropical Diseases Diagnosis industry

Leading Neglected Tropical Diseases Diagnosis companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Neglected Tropical Diseases Diagnosis companies.

Neglected Tropical Diseases Diagnosis Market Study- Strategic Analysis Review

The Neglected Tropical Diseases Diagnosis market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-

• Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
• Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
• Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
• Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.

Neglected Tropical Diseases Diagnosis Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Neglected Tropical Diseases Diagnosis industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.

Neglected Tropical Diseases Diagnosis Country Analysis and Revenue Outlook to 2030

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.

North America Neglected Tropical Diseases Diagnosis Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Neglected Tropical Diseases Diagnosis market segments. Similarly, Strong end-user demand is encouraging Canadian Neglected Tropical Diseases Diagnosis companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Neglected Tropical Diseases Diagnosis market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Neglected Tropical Diseases Diagnosis Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Neglected Tropical Diseases Diagnosis industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Neglected Tropical Diseases Diagnosis market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Neglected Tropical Diseases Diagnosis Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Neglected Tropical Diseases Diagnosis in Asia Pacific. In particular, China, India, and South East Asian Neglected Tropical Diseases Diagnosis markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.

Latin America Neglected Tropical Diseases Diagnosis Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Neglected Tropical Diseases Diagnosis Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Neglected Tropical Diseases Diagnosis market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Neglected Tropical Diseases Diagnosis.

Neglected Tropical Diseases Diagnosis Market Company Profiles

The global Neglected Tropical Diseases Diagnosis market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott, Coris BioConcept, DiaSys Diagnostic Systems GmbH, F. Hoffmann-La Roche Ltd, Genome Diagnostics Pvt Ltd, InBios International Inc, Omega Diagnostics Group PLC, Oscar Medicare Pvt Ltd, Thermo Fisher Scientific Inc, ZeptoMetrix

Recent Neglected Tropical Diseases Diagnosis Market Developments

The global Neglected Tropical Diseases Diagnosis market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Neglected Tropical Diseases Diagnosis Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis

• Pricing Analysis
• Value Chain Analysis
• SWOT Profile
• Market Dynamics- Trends, Drivers, Challenges
• Porter’s Five Forces Analysis
• Macroeconomic Impact Analysis
• Case Scenarios- Low, Base, High

Market Segmentation:

By Disease

Dengue

Chikungunya

Rabies

Leprosy

Buruli ulcer

Yaws

Lymphatic Filariasis

Taeniasis/Cysticercosis

Foodborne trematode infections

Echinococcosis

Chagas disease

Dracunculiasis

Human African trypanosomiasis (sleeping sickness)

Soil-transmitted helminthiases

Onchocerciasis

Schistosomiasis

Scabies

Snakebite Envenoming

Leishmaniases

By Diagnostic Method

Conventional Method

Molecular/Modern Method

By Service

Centralized Service

POC Service

By End-user

Clinical Labs

Hospitals /Clinics

Home Healthcare

Geographical Segmentation:

• North America (3 markets)
• Europe (6 markets)
• Asia Pacific (6 markets)
• Latin America (3 markets)
• Middle East Africa (5 markets)

Companies

Abbott

Coris BioConcept

DiaSys Diagnostic Systems GmbH

F. Hoffmann-La Roche Ltd

Genome Diagnostics Pvt Ltd

InBios International Inc

Omega Diagnostics Group PLC

Oscar Medicare Pvt Ltd

Thermo Fisher Scientific Inc

ZeptoMetrix

Formats Available: Excel, PDF, and PPT